Calidi Biotherapeutics issues warrant for 17.4M shares at $0.23 in private placement

Calidi Biotherapeutics, Inc.

Warrant to purchase up to 17,391,304 shares of common stock at $0.23 per share issued to accredited investor.
Warrant first exercisable on September 8, 2026; vesting tied to future registered issuances of up to $4.0M.
Registered issuances may occur before July 8, 2026 but neither party is obligated to complete them.
Issuance exempt under Section 4(a)(2) and Rule 506(b) based on investor's accredited status.
Shares issuable upon exercise are restricted; no registration statement filed for resale.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

Calidi Biotherapeutics, Inc. issued up to 17,391,304 (unvested) shares of common stock of warrant to an accredited investor.

Security: warrant
Shares: up to 17,391,304 (unvested) shares of common stock
Purchaser: an accredited investor

Exact text from the filing

On May 6, 2026, Calidi Biotherapeutics, Inc. (the “Company”) issued a warrant (the “Warrant”) to purchase up to 17,391,304 (unvested) shares of common stock of the Company, par value $0.0001 per share (the “Common Stock”), with an exercise price of $0.23 to an accredited investor in a private placement transaction.

View on SEC.gov

Browse all equity issuances →

Calidi Biotherapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-022024

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.